Thursday June 22, 2017
Time
Ambassador Ballroom
Diplomat Ballroom
Palladian Ballroom
Executive Room
Workshop 1:
How Adherence to Guidelines Influences the Cost Effectiveness of
Supportive Care Interventions
Chair: Bernardo Rapoport, South-Africa
Workshop 2:
Update on Venous Thromboembolism: Approach and Challenges
Co-Chair: Carme Font
Co-Chair: Carmen Escalante
Co-Chair: Tom Butler
Co-Chair: Paz Fernandez
Workshop 3:​​ ​
Integration of Oncology and Palliative Care: Why? What? Who? When?
How?​
Workshop Chair: David Hui
Workshop 1 cont.
Workshop 2 cont.
Workshop 3 cont.
07:30 - 09:30
Congressional A
Workshop 4:
Communication Challenges in Geriatric Oncology: Perspectives of
Patients, Family Caregivers and Healthcare Professionals
Chair: Christopher Steer
Chair: Lidia Schiapira
Chair: Penny Schofield
Chair: Fran Boyle
Chair: Holly Holmes
Chair: Belinda Kiely
Workshop 5:
Circadian Rhythms and Chronobiology in Cancer:
Relationship to Cancer-related Fatigue and Other
Toxicities
Chair: Oxana Palesh
Chair: Diwakar Balachandran
Workshop 4 cont.
Workshop 5 cont.
Congressional B
Coffee Break
09:30 - 10:00
10:00 - 11:30
11:30 - 12:15
Opening Ceremony
12:15 - 13:45
Industry Symposium
13:45 - 14:00
Break
Plenary 1: Financial Toxicity
Chair: Ian Olver, Australia
14:00-15:00
15:00 - 15:30
15:30 - 16:30
1. Introduction - Ian Olver, Australia (2 min.)
2. The financial hazard of personalised medicine and supportive care Pricivel Carrera, The Netherlands (29 min)
3. Utilising value-based assessments in medical oncology -Ronan Kelly, USA
(29 min)
4. Developing the Cost Score for Financial Toxicity - Jonas de Souza, USA (29
min)
Parallel Session 1
Young Investigator Session
Chair: David Warr, Canada
Co-Chair: Rachel Gibson, Australia
Parallel Session 2
Bone Health in Cancer: Advances in research and clinical practice
Chair: Cesar Migliorati, USA
Co-Chair: Catherine Van Poznac, USA
Parallel Session 3
Clinical tobacco intervention: role in supportive care
Chair: Debbie Saunders, USA
Co-Chair: TBA
Parallel Session 4
JBI Session/ Disability on Cancer
Chair: Joanne Bowen, Australia
Co-chair: TBA
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
1. Introduction: The intersection of Bone health and Oral Health - Cesar
Miglorati, USA (10 min)
2. Atypical femur fractures - Beatrice Edwards, USA (18 min)
3. Immunotherapy and bone health - Winston Tan (18 min)
4. Localised dental/periodontal disease: early stage of osteonecrosis of the
jaw? Ourania Nicolaotou-Galitis, Greece (18 min)
5. Proffered Paper (10 min)
6. Proffered Paper (10 min)
1. Introduction - Debbie Saunders, USA (10 min)
2. Why address Tobacco use and cessation in Cancer - Bill Evans, Canada (15
min)
3. Toxicities, morbidity, morality - Meredith Giuliani, Canada (15 min)
4. Economic Evaluation of Smoking Cessation, Lisa Masucci, Canada (15 min)
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
1. Introduction - Joanne Bowen, Australia (2 min)
2. The impact of cancer related disability and unmet needs of people with
cancer related disability - Edoardo Aromataris , Australia (20 min)
3. Psychological impairments in people with cancer - Catalin Tufanaru,
Australia (20 min)
4. The impact of prehabilitation on health and wellbeing outcomes and it's
acceptability to people affected by cancer - Micah Peters, Australia (20 min)
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
16:30 - 17:00
17:00 - 17:30
17:30 - 18:30
18:30 - 19:00
19:00 - 21:30
SG 1
SG 2
SG 3
SG 4
SG 8
SG 9
Coffee Break
Industry Symposium
SG 5
SG 6
Welcome Reception, awards Ceremony @ Exhibition
SG 7
Friday June 23,2017
Time
Ambassador Ballroom
Diplomat Ballroom
08:00 - 09:00
09:00 - 10:30
Palladian Ballroom
Industry Symposium
Industry Symposium
Parallel Session 5
Neurological Complications
Chair: Charles Loprinzi, USA
Co-Chair: TBA
Parallel Session 6
Palliative Care
Chair: Gregory Crawford, Australia
Co-Chair: TBA
Parallel Session 7
Integrating oncodermatology into practice: state of the science
Chair: Mario Lacouture, USA
Co-chair: TBA
1. Introduction - Chair: Charles Loprinzi, USA (2 min)
2. Does topical cryotherapy decrease paclitaxel-associated neuropathy? - Charles Loprinzi, USA
(20 min)
3. Are obesity and diabetes established risk factors for the development of chemotherapy
neuropathy? - Healther Greenlee, USA (20 min)
4. Is exercise helpful for prevention of chemotherapy neuropathy? - Ian Kleckner, USA (20 min)
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
1. Introduction - Gregory Crawford, Australia (10 min)
2. Cancer pain relief - overcoming the barriers - Judith Paice, USA (20 min)
3. Managing patients at different stages of the cancer journey - Mellar Davis, USA (20 min)
4. Opioids: the good, the bad, the ugly - Andrew Davies, UK (20 min)
5. Proffered Paper (10 min)
6. Proffered Paper (10 min)
1. Introduction to oncoderamtology and focus on dermatologic toxicities from chemotherapy - Mario
Lacouture, USA (2 min)
2. Dermatologic toxicities associated with targeted and immunotherapies - Jennifer Choi, USA (20 min)
3. Dermatologic toxicities associated with radiation therapy - Rebecca Wong Can, USA (20 min)
4. Nursing role: assessment and patient education - Kathryn Ciccolini, USA (20 min)
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
10:30 - 11:00
Executive Room
Exhibition
Exhibition
Exhibition
SG 10
Educational Session: How to write a manuscript for
supportive care in cancer
Chair: Fred Ashbury, Canada
Chair: Ian Olver, Australia
Co-Chair: Paul Hesketh, USA
Fatigue
E-Poster Presentations 7
Chair: TBA
Chair: TBA
Rehabilitation
E-Poster Presentations 20
Chair: TBA
Chair: TBA
Oral Care
E-Poster Presentations 3
Chair: TBA
Chair: TBA
Quality of Life 1
E-Poster Presentations 18
Chair: TBA
Chair: TBA
Quality of Life 2
E-Poster Presentations 19
Chair: TBA
Chair: TBA
Psychooncology
E-Poster Presentations 11
Chair: TBA
Chair: TBA
Antiemetics
E-Poster Presentations 1
Chair: TBA
Chair: TBA
Palliative Care 1
E-Poster Presentations 16
Chair: TBA
Chair: TBA
Palliative Care 2
E-Poster Presentations 17
Chair: TBA
Chair: TBA
Bone and Cancer Pain 1
E-Poster Presentations 2
Chair: TBA
Chair: TBA
Education 1
E-Poster Presentations 5
Chair: TBA
Chair: TBA
Education 2 + Geriatrics
E-Poster Presentations 6
Chair: TBA
Chair: TBA
1. Introduction by Panel (10 min)
2. The Editors perspective - Fred Ashbury, Canada (27
min)
3. The Author's perspective - Paul Hesketh, USA (27
min)
4. The reviewer's review - Ian Olver, Australia (27 min)
Coffee Break, Visit Exhibition & E-poster
Plenary 2: Side Effects of Immunotherapy
Chair: David Warr, Canada
11:00 - 12:30
1. Introduction - David Warr, Canada (2 min)
2. Immunotherapy and dermatological toxicities - Mario Lacouture, USA (29 min)
3. Immunotherapy: nausea and vomiting aspects of new drugs - Karin Jordan, Germany (29 min)
4. Immunotherapy-induced mucositis - Joel Epstein, USA (29 min)
12:30 - 13:30
SG 11
Industry Symposium
13:30-14:00
Parallel Session 8
ONS/MASCC Joint Session
Chair & Moderator: Lisa Kennedy Sheldon, USA
14:00 - 15:00
Parallel Session 9
Challenges in pain control in pediatric oncology
Chair: Marianne van de Wetering, The Netherlands
Co-Chair: Andrea Orsey, USA
Parallel Session 10
MASCC Cancer-Related Fatigue Treatment Guidelines
Chair: Karen Mustian, USA
Co-Chair: Debra Barton, USA
1. What is financial toxicity and how can it be evaluated? - Pricivel Carrera, The Netherlands (10
min)
2. How do we assign value to cancer treatments? - Ronan Kelly, USA (10 min)
3. What is financial distress and patient choice associated with cancer treatment? - Ian Olver,
Australia (10 min)
4. What is the patient/caregiver experience of financial toxicity? -Alice Beers, USA (10 min)
5. What is the distress caused by Financial Toxicity - Lisa Kennedy Sheldon, USA (10 min)
6. How do we assess financial distress and communicate with patients? - Christina Bach, USA (10
min)
7. Panel and Audience Interaction (30 min)
1. Introduction - Marianne van de Wetering, The Netherlands (10 min)
2. Doctor my pain is still a 10 (how to measure pain in children including special populations such
as very young or nonverbal children) - Erik Loeffen, The Netherlands (20 min)
3. Pain control during the palliative phase. Doctor what if morphine does not work anymore in my
child? - Justin Baker, USA (20 min)
4. When nothing seems to work, doctor can I use Cannabis to decrease pain in my child ? (use of
CAM etc) - Andrea Orsey, USA (20 min)
5. Proffered Paper (10 min)
6. Proffered Paper (10 min)
1. Introduction & Presentation of Methods for Development of Guidelines - Karen Mustian, USA (10
min.)
2. Review of Pharmaceutical Intervention Randomized Clinical Trials For CRF - Sriam Yennu, USA (15 min)
3. Review of Exercise Intervention Randomized Clinical Trials For CRF - Stephen Samuel, India (15 min)
4. Review of Psychosocial Intervention Randomized Clinical Trials For CRF - Karin Olson, Canada (15 min)
5. Review of Complementary and Integrative Intervention Randomized Clinical Trials For CRF - Luke
Peppone, USA (15 min)
6. Presentation of Final MASCC CRF Treatment Guidelines - Karen Mustian, USA (20 min)
Parallel Session 11
Reproduction across the lifecourse of the female cancer patient
Chair: Sarah Temkin, USA
Co-Chair: Debra Barton, USA
Parallel Session 12
Neutropenia, Infection and Myelosuppression Study Group
Chair: Bernardo Rapoport, South Africa
Co-Chair: TBA
Parallel Session 13
Mucositis: outcome measures
Chair: Sharon Elad, USA
Co-Chair: TBA
1. Introduction - Sarah Temkin, USA & Debra Barton, USA (10 min)
2. Beyond hot flashes – addressing menopause for cancer survivors - Andrew Kaunitz, USA (20
min)
3. Planning a pregnancy and non-contraceptive benefits of contraception for adolescents and
young adults (AYA) with cancer - Aletha Akers, USA (20 min)
4. Sex after Cancer: Improving sexual health for the female cancer patient - Jeanner Carter, USA
(20 min)
5. Onco-fertility - Lisa Kolp, USA (20 min)
1. Introduction - Bernardo Rapoport, South Africa (2 min)
2. Cost effectiveness and cost savings associated with appropriate prophylactic G-CSF usage Matti Aapro, Switzerland (15 min).
3. Cost effectiveness of guideline directed therapy in supportive care - Jean Klastersky, Belgium
(15 min).
4. Outpatient antibiotic therapy of febrile neutropenia, patient selection and cost implications Bernardo Rapoport, South Africa (15 min)
5. Misuse of prophylactic antibiotics: what is the true cost - Stephen Zinner, USA (15 min).
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
1. Introduction - Sharon Elad, USA (10 min)
2. Outcome measures: oral mucositis - Debbie McGuire, USA (14 min)
3. Outcome measures: GI mucositis - Nicole Blijlevens, The Netherlands (14 min)
4. Outcome measures: targeted therapy mucositis - Joel Epstein, USA (14 min)
5. Outcome measures: quality of life and mucositis - Noam Yarom, Israel (14 min)
6. Proffered Paper (10 min)
7. Proffered Paper (10 min)
Parallel Session 14
Mucositis Proffered Papers
Chair: TBA
Co-Chair: TBA
Parallel Session 15
Health related quality of life across the cancer trajectory
Chair: Ann O'Mara, USA
Chair: TBA
Parallel Session 16
Cancer and the sensorium: influences and implications for taste, smell, touch, vision and hearing
Chair: Anna Boltong, Australia
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
1. Introduction - Ann O'Mara, USA (10 min)
2. HRQOL at the time of initial diagnosis and during the treatment phase - Deborah WatkinsBruner, USA (20 min)
3. HRQOL concerns during the survivorship - Debra Barton, USA (20 min)
4.HRQOL concerns when disease progresses/during advanced disease management - Betty Ferrel,
USA (20 min)
5. Proffered Paper (10 min)
6. Proffered Paper (10 min)
15:00 - 15:30
15:30 - 16:00
16:00 - 17:00
Coffee Break & E-Poster
SG 12
MASCC Business Meeting
SG 13
17:00 - 17:30
17:30:18:30
18:30 - 19:00
19:30 - 22:00
MASCC Presidential Dinner
1. Introduction: what is the sensorium and how is it affected by cancer - Anna Boltong, Australia
2. Eating with your eyes - how do the senses interact with neural mechanisms to drive food enjoyment
and ultimately health outcomes? - Kathleen Keller, USA (20 min)
3. Chemosensory variation and disease risk - Valerie Duffy, USA (20 min)
4. Patient Stories (25 min)
5. Panel Discussion - Rachel Gibson, Australia (15 min)
SG 14
Saturday June 24, 2017
Time
Ambassador Ballroom
07:00 - 08:00
08:00 - 09:00
Parallel Session 17
Geriatric assessment as a supportive care strategy - how can technology help patients and
clinicians care for older adults with cancer?
Chair: Christopher Steer, Australia
Co-Chair: TBA
Parallel Session 18
Psychosocial Proffered Papers
Chair: Lidia Schapira, USA
Co-chair: TBA
1. Introduction - Christopher Steer, Australia (10 min)
2. Electronic geriatric assessment (eCGA) in older adults with cancer - the MSKCC experience Armin Shahrokni, USA (20 min)
3. Can the oncology community learn from geriatricians about how to apply technology? The
InterRAI experience - unlocking the power of data - Len Gray, Australia (20 min)
4. Computerised, algorithm-based clinical decision support in a supportive care clinic - Mary E
Cooley, USA (20 min)
5. Proffered Paper (10 min)
6. Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Diplomat Ballroom
Palladian Ballroom
Executive Room
Geriatrics
Nutrition Cachexia
Oral Care
Parallel Session 19
Wound Care in Oncology
Chair: Mario Lacouture, USA
Co-Chair: TBA
Parallel Session 20
Scalp Coooling Session
Chair: Fran Boyle, Australia
Co-Chair: Annie Young, Australia
Parallel Session 21
Challenges in antiemetics
Chair: Matti Aapro, Switzerland
Co-Chair: TBA
Parallel Session 22
South East Asia Session
Chair: Ian Olver, Australia
Chair: Kazuo Tamura, Japan
1. Introduction -Fran Boyle, Australia & Annie Young, Australia (10 min)
2. Advances in scalp cooling research from the Netherlands - Corina van den Hurk, The
Netherlands (20 min).
3. US randomised trial of Paxman scalp cooling device - Julie Nangia, USA (20 min).
4. Implementation of scalp cooling in the US - Hope Rugo, USA (20 min)
5. Managing hair loss from endocrine agents - Mario Lacouture, USA (10 min).
5. Proffered Paper (10 min)
1. Introduction - Matti Aapro, Switzerland (2 min)
2, What is nausea? A hypothesis for the future: Richard Gralla, USA (10 min)
3. What is nausea? It is not what we believe - Matti Aapro Switzerland (10 min)
4. Discussion (10 min)
5. Olanzapine: a prime drug or not? A debate;
In Favour Rudolf Navari, USA (10 min).
Against: Fausto Roila, Italy (10 min)
Questions and Answers (10 min)
6. Antiemetics decrease the cost of treatment - David Warr, Canada (10 min)
7. The South African calculations - Bernardo Rapoport, South Africa (10 min).
8. Q&A (10 min)
1. Introduction - Ian Olver, Australia (2 min)
2. Overview of an early palliative care on various outcomes in advanced cancer patients - TBA (20
min)
Break (30 min)
3. Why early palliative care interventions work and how they should be implemented over the
world? - David Hui, USA (20 min)
4. Cancer treatment system in Japan--networking of designated regional cancer treatment
hospitals implemented by Cancer Control Act of Japan - Kazuo Tamura, Japan (15 min)
5. What are the barriers to and facilitators for the implementation of early palliative care in
Japan? - Takako Nakajima, Japan (20 min)
5 .Discussion (12 min)
Parallel Session 23
Nutrition, Cachexia and antiemetics Proffered Papers
Chair: Anna Boltong, Australia
Parallel Session 24
Cross Cultural Communication in Cancer Care
Chair: Lidia Schapira, USA
Co-Chair: TBA
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
1. Introduction - Lidia Schapira, USA (10 min)
2. Understanding how implicit bias undermines cancer care - VJ Periyakoil, USA (18 min)
3. Present and future challenges for Cultural Competence in supportive cancer care - Sandra
Michiels, Belgium (18 min)
4. The role of medical interpreters in facilitating communication in cancer care - Phyllis Butow,
Australia (18 min)
5. Proffered Paper (8 min)
6. Proffered Paper (8 min)
7. Proffered Paper (8 min)
Break
Plenary 3: Precision Medicine
Chair: Rachel Gibson, Australia
15:00 - 16:00
Neurological complications +
Nutrition and Cachexia
E-Poster Presentations 9
Chair: TBA
Chair: TBA
Paediatrics + Toxicity of AntiCancer Therapy
E-Poster Presentations 12
Chair: TBA
Chair: TBA
1. Paediatric oral oncology – management of acute toxicities - Eric Loeffen, The Netherlands (25
min)
2. Long term effects of cancer treatment that occur in children - Catherine Hong, Singapore (25
min)
3. Maxillofacial reconstruction in paediatric patients - Caroline Nguyen, Canada (25 min)
4. Panel Discussion (15 min)
Survivorship
E-Poster Presentations 21
Chair: TBA
Chair: TBA
Cancer Pain 2
E-Poster Presentations 4
Chair: TBA
Chair: TBA
Neutropenia-Infections + Other
1
E-Poster Presentations 14
Chair: TBA
Chair: TBA
Late Breaking + Lymphedema +
Respiratory + Skin Toxicity +
Throboembolic events
E-Poster Presentations 13
Chair: TBA
Chair: TBA
Other 2
E-Poster Presentations 15
Chair: TBA
Chair: TBA
E-Poster Presentations 10
Chair: TBA
Chair: TBA
Osteonecrosis of the Jaws
Chair: TBA
Coffee Break
13:00 - 13:30
14:30 - 15:00
Mucositis
E-Poster Presentations 8
Chair: TBA
Chair: TBA
ISOO CE Course and Business Meeting
Parallel Session 25 - Taste of Vienna
Chair: Rachel Gibson, Australia
Co-Chair: TBA
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
Proffered Paper (10 min)
1. Surgical management of osteoradionecrosis and medication-related osteonecrosis of the jaws David Yang, USA (40 min)
2. Assessment and management of patients at risk for osteonecrosis of the jaws - Cesar
Migliorati, USA (40 min)
3. Panel Discussion - (10 min)
Break
Research updates from around the world
Chair: TBA
12:30 - 13:00
13:30 - 14:30
Exhibition
Oral Oncology in the Paediatric Setting
Chair: TBA
11:00 - 11:30
11:30 - 12:30
Exhibition
1. Introduction - Mario Lacouture, USA and Anna Skripnik Lucas, USA (10 min)
2. Principles of Wound Care in Oncology - Anna Skripnik Lucas, USA (15 min)
3. Atypical Wounds in Oncology - Alina Markova, USA (15 min)
4. Management of Malignant Wounds/Cutaneous Metastasis - Jae Jung, USA (15 min)
5. Q&A - Panel
09:00 - 09:30
09:30 - 11:00
Exhibition
1. Introduction - Rachel Gibson, Australia (2 min)
2. Immunogenetics of treatment toxicity - Joanne Bowen, Australia (29 min)
3. Beyond the Human Genome: Use of Genetics to Improve Cancer Pain Treatment- Janet Coller,
Australia (29 min)
4. Radiogenomics - current and future perspectives - Nicolaj Andreassen, Denmark (29 min)
Oral Oncology Research
Chair – TBA
1. Oral complications after Radiation Therapy for Head and Neck Cancer - Raj Lalla (20 min)
5. Proffered Paper (15 min)
6. Proffered Paper (15 min)
7. Proffered Paper (15 min)
5. Discussion (15 min)
Closing Ceremony
ISOO Annual General Meeting
Chair: Allan Hovan